{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:27:52Z","timestamp":1767144472085,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.canlet.2018.05.022","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000}}],"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research Foundation","award":["17DZ2260200"],"award-info":[{"award-number":["17DZ2260200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773043"],"award-info":[{"award-number":["81773043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31501127"],"award-info":[{"award-number":["31501127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"development fund for Shanghai talents","award":["201608"],"award-info":[{"award-number":["201608"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.canlet.2018.05.022","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T12:46:59Z","timestamp":1526561219000},"page":"97-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["RETRACTED: EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK\/ERK pathway"],"prefix":"10.1016","volume":"430","author":[{"given":"Qiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-3715","authenticated-orcid":false,"given":"Maolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-0185","authenticated-orcid":false,"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.05.022_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/967472","article-title":"Gallbladder cancer in the 21st century","volume":"2015","author":"Kanthan","year":"2015","journal-title":"J Oncol"},{"key":"10.1016\/j.canlet.2018.05.022_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2018.05.022_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","article-title":"Gallbladder cancer: can newer insights improve the outcome?","volume":"27","author":"Dutta","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2018.05.022_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-016-0370-7","article-title":"The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR","volume":"35","author":"Zhao","year":"2016","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.05.022_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gtc.2010.02.006","article-title":"Management of gallbladder cancer","volume":"39","author":"Jayaraman","year":"2010","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.canlet.2018.05.022_bib6","first-page":"221","article-title":"Gallbladder cancer","volume":"3","author":"Rakic","year":"2014","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.canlet.2018.05.022_bib7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2018.05.022_bib8","first-page":"199","article-title":"EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer","volume":"1868","author":"Yi-Wen","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2018.05.022_bib9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/0008-5472.CAN-04-4283","article-title":"EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma","volume":"65","author":"Alaminos","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2018.05.022_bib10","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1523\/JNEUROSCI.17-14-05493.1997","article-title":"HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural development and injury","volume":"17","author":"Bolin","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.canlet.2018.05.022_bib11","doi-asserted-by":"crossref","first-page":"34859","DOI":"10.18632\/oncotarget.5414","article-title":"Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K\/Akt pathway","volume":"6","author":"Hsieh","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.05.022_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.juro.2013.12.001","article-title":"Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway","volume":"192","author":"Wang","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2018.05.022_bib13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/14728220902988549","article-title":"EMP3 as a candidate tumor suppressor gene for solid tumors","volume":"13","author":"Fumoto","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2018.05.022_bib14","first-page":"300","article-title":"The methylation analysis of EMP3 and PCDH-gamma-A11 gene in human glioma","volume":"48","author":"Jiang","year":"2010","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.canlet.2018.05.022_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2008.08.021","article-title":"EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma","volume":"274","author":"Fumoto","year":"2009","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2018.05.022_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.05.022_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.05.022_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2018.05.022_bib19","first-page":"2819","article-title":"MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation","volume":"12","author":"Liu","year":"2011","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2018.05.022_bib20","doi-asserted-by":"crossref","first-page":"10973","DOI":"10.1074\/jbc.M112.434340","article-title":"The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2)","volume":"288","author":"Hu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.05.022_bib21","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1038\/onc.2011.629","article-title":"MiR-663, a microRNA targeting p21(WAF1\/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma","volume":"31","author":"Yi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.05.022_bib22","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1158\/1078-0432.CCR-14-2807","article-title":"miR-663 suppresses oncogenic function of CXCR4 in glioblastoma","volume":"21","author":"Shi","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.05.022_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-015-0315-3","article-title":"miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer","volume":"14","author":"Zang","year":"2015","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2018.05.022_bib24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1600-0463.2007.apm_775.xml.x","article-title":"MicroRNAs and cancer","volume":"115","author":"Cowland","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.canlet.2018.05.022_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2015.01.041","article-title":"Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer","volume":"360","author":"Cao","year":"2015","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2018.05.022_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2017.09.030","article-title":"CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2","volume":"412","author":"Xu","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2018.05.022_bib27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"87","author":"Sinha","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.canlet.2018.05.022_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.05.022_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.27","article-title":"MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1alpha expression","volume":"7","author":"Lou","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2018.05.022_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-015-0423-0","article-title":"MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway","volume":"14","author":"Xia","year":"2015","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2018.05.022_bib31","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI38019","article-title":"Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease","volume":"119","author":"Acloque","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2018.05.022_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066676","article-title":"Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas","volume":"8","author":"Long","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.05.022_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1245\/ASO.2004.03.011","article-title":"Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer","volume":"11","author":"Hawkins","year":"2004","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2018.05.022_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2014.08.036","article-title":"Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL\/MAPK pathway","volume":"355","author":"Li","year":"2014","journal-title":"Canc. Lett."},{"issue":"4","key":"10.1016\/j.canlet.2018.05.022_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11605-017-3655-z","article-title":"Incidental gallbladder carcinoma discovered after laparoscopic cholecystectomy: identifying patients who will benefit from reoperation","volume":"22","author":"Addeo","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.canlet.2018.05.022_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/dc.21821","article-title":"MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma","volume":"41","author":"Liu","year":"2013","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.canlet.2018.05.022_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yexmp.2013.07.001","article-title":"Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer","volume":"95","author":"Xue","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.canlet.2018.05.022_bib38","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.3892\/mmr.2015.4326","article-title":"Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma","volume":"12","author":"Hong","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2018.05.022_bib39","first-page":"293","article-title":"Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells","volume":"8","author":"Kim","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.canlet.2018.05.022_bib40","first-page":"105","article-title":"Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells","volume":"24","author":"Pan","year":"2010","journal-title":"Oncol. Rep."},{"issue":"30","key":"10.1016\/j.canlet.2018.05.022_bib41","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1038\/onc.2016.500","article-title":"TGF\u03b2 engages MEK\/ERK to differentially regulate benign and malignant pancreas cell function","volume":"36","author":"Principe","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.05.022_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1158\/0008-5472.CAN-13-2381","article-title":"ERKs in cancer: friends or foes?","volume":"74","author":"Desch\u00eanes-Simard","year":"2014","journal-title":"Canc. Res."}],"updated-by":[{"DOI":"10.1016\/j.canlet.2022.215932","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"record-id":"40203"},{"DOI":"10.1016\/j.canlet.2018.05.022","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000}},{"DOI":"10.1016\/j.canlet.2022.215932","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518303537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518303537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:40:10Z","timestamp":1759592410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518303537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":42,"alternative-id":["S0304383518303537"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.05.022","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK\/ERK pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}